SEDANS logo

Sedana Medical BATS-CHIXE:SEDANS Stock Report

Last Price

SEK 25.28

Market Cap

SEK 2.3b

7D

0%

1Y

n/a

Updated

14 Sep, 2024

Data

Company Financials +

Sedana Medical AB (publ)

BATS-CHIXE:SEDANS Stock Report

Market Cap: SEK 2.3b

SEDANS Stock Overview

A medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally.

SEDANS fundamental analysis
Snowflake Score
Valuation0/6
Future Growth2/6
Past Performance0/6
Financial Health6/6
Dividends0/6

Sedana Medical AB (publ) Competitors

Price History & Performance

Summary of all time highs, changes and price drops for Sedana Medical
Historical stock prices
Current Share PriceSEK 25.28
52 Week HighSEK 0
52 Week LowSEK 0
Beta0.22
11 Month Change0%
3 Month Changen/a
1 Year Changen/a
33 Year Changen/a
5 Year Changen/a
Change since IPO41.44%

Recent News & Updates

Recent updates

Shareholder Returns

SEDANSGB Medical EquipmentGB Market
7D0%-3.0%-0.5%
1Yn/a5.1%7.1%

Return vs Industry: Insufficient data to determine how SEDANS performed against the UK Medical Equipment industry.

Return vs Market: Insufficient data to determine how SEDANS performed against the UK Market.

Price Volatility

Is SEDANS's price volatile compared to industry and market?
SEDANS volatility
SEDANS Average Weekly Movementn/a
Medical Equipment Industry Average Movement5.7%
Market Average Movement4.7%
10% most volatile stocks in GB Market9.4%
10% least volatile stocks in GB Market2.6%

Stable Share Price: SEDANS has not had significant price volatility in the past 3 months.

Volatility Over Time: Insufficient data to determine SEDANS's volatility change over the past year.

About the Company

FoundedEmployeesCEOWebsite
199981Johannes Dollwww.sedanamedical.com

Sedana Medical AB (publ), a medtech and pharmaceutical company, develops, manufactures, and sells medical devices and pharmaceutical products in Sweden, Germany, and internationally. The company offers Sedaconda ACD-L and Sedaconda ACD-S, which are disposable medical devices that enable the administration of volatile anaesthetics; Sedaconda Syringe, a 50/60ml syringe; Sedaconda ACD starter kit; and Sedaconda (Isoflurane) for sedation of mechanically ventilated adult patients during intensive care, as well as AnaConDa, a medical device enabling administration of inhaled anaesthetics. It also provides FlurAbsorb and FlurAbsorb-S, which are active carbon filters to capture waste anaesthetic gases from the exhaust of the ventilator; Scavenging tube, a one piece pre-connected tube designed to channel anaesthetic waste gas from the ventilator exhaust port and the gas monitor exhaust port to the FlurAbsorb filter; FlurAbsorb mount to hold the FlurAbsorb during scavenging of anesthetic gas; FlurAbsorb-S mount to hold the FlurAbsorb-S during scavenging of anesthetic gas; FlurAbsorb accessory kit comprising accessories to connect the exhaust of the ventilator and the gas monitor to the FlurAbsorb/FlurAbsorb-S; and Mindray exhaust connector, which enables to connect the exhaust of the ventilator to an active or passive scavenging system.

Sedana Medical AB (publ) Fundamentals Summary

How do Sedana Medical's earnings and revenue compare to its market cap?
SEDANS fundamental statistics
Market capSEK 2.31b
Earnings (TTM)-SEK 41.47m
Revenue (TTM)SEK 168.68m

13.7x

P/S Ratio

-55.7x

P/E Ratio

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
SEDANS income statement (TTM)
RevenueSEK 168.68m
Cost of RevenueSEK 50.06m
Gross ProfitSEK 118.62m
Other ExpensesSEK 160.09m
Earnings-SEK 41.47m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

Oct 24, 2024

Earnings per share (EPS)-0.42
Gross Margin70.32%
Net Profit Margin-24.59%
Debt/Equity Ratio0%

How did SEDANS perform over the long term?

See historical performance and comparison